Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Agile Therapeutics (AGRX) stock

Learn how to easily invest in Agile Therapeutics stock.

Agile Therapeutics, Inc
-$0.01 (-0.89%)

Agile Therapeutics, Inc is a drug manufacturers-specialty & generic business based in the US. Agile Therapeutics shares (AGRX) are listed on the NASDAQ and all prices are listed in US Dollars. Agile Therapeutics employs 28 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Agile Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AGRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Agile Therapeutics stock price (NASDAQ: AGRX)

Use our graph to track the performance of AGRX stocks over time.

Agile Therapeutics shares at a glance

Information last updated 2021-07-22.
Latest market close$1.61
52-week range$1.14 - $3.89
50-day moving average $1.38
200-day moving average $2.08
Wall St. target price$6.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Buy Agile Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Agile Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Agile Therapeutics price performance over time

Historical closes compared with the close of $1.61 from 2021-05-28

1 week (2021-07-17) N/A
1 month (2021-06-28) 19.26%
3 months (2021-04-28) -12.50%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

Agile Therapeutics financials

Revenue TTM $865,000
Gross profit TTM $467,000
Return on assets TTM -42.81%
Return on equity TTM -97.24%
Profit margin 0%
Book value $0.40
Market capitalisation $106.8 million

TTM: trailing 12 months

Shorting Agile Therapeutics shares

There are currently 2.8 million Agile Therapeutics shares held short by investors – that's known as Agile Therapeutics's "short interest". This figure is 57.1% down from 6.5 million last month.

There are a few different ways that this level of interest in shorting Agile Therapeutics shares can be evaluated.

Agile Therapeutics's "short interest ratio" (SIR)

Agile Therapeutics's "short interest ratio" (SIR) is the quantity of Agile Therapeutics shares currently shorted divided by the average quantity of Agile Therapeutics shares traded daily (recently around 1.2 million). Agile Therapeutics's SIR currently stands at 2.3. In other words for every 100,000 Agile Therapeutics shares traded daily on the market, roughly 2300 shares are currently held short.

However Agile Therapeutics's short interest can also be evaluated against the total number of Agile Therapeutics shares, or, against the total number of tradable Agile Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Agile Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Agile Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0389% of the tradable shares (for every 100,000 tradable Agile Therapeutics shares, roughly 39 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Agile Therapeutics.

Find out more about how you can short Agile Therapeutics stock.

Agile Therapeutics share dividends

We're not expecting Agile Therapeutics to pay a dividend over the next 12 months.

Agile Therapeutics share price volatility

Over the last 12 months, Agile Therapeutics's shares have ranged in value from as little as $1.14 up to $3.89. A popular way to gauge a stock's volatility is its "beta".

AGRX.US volatility(beta: 0.95)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Agile Therapeutics's is 0.951. This would suggest that Agile Therapeutics's shares are less volatile than average (for this exchange).

Agile Therapeutics overview

Agile Therapeutics, Inc. , a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. .

Frequently asked questions

What percentage of Agile Therapeutics is owned by insiders or institutions?
Currently 1.071% of Agile Therapeutics shares are held by insiders and 48.436% by institutions.
How many people work for Agile Therapeutics?
Latest data suggests 28 work at Agile Therapeutics.
When does the fiscal year end for Agile Therapeutics?
Agile Therapeutics's fiscal year ends in December.
Where is Agile Therapeutics based?
Agile Therapeutics's address is: 101 Poor Farm Road, Princeton, NJ, United States, 08540
What is Agile Therapeutics's ISIN number?
Agile Therapeutics's international securities identification number is: US00847L1008
What is Agile Therapeutics's CUSIP number?
Agile Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00847L100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site